Prostate cancer is the most common malignancy in the reproductive system of older males.
Androgen deprivation therapy (ADT) is an important treatment for prostate cancer patients …

Prostate cancer is the most commonly diagnosed cancer and the second leading cause of
cancer-related death among men in western countries. Androgen deprivation therapy (ADT) …

Prostate cancer tissue is composed of both cancer cells and host cells. The milieu of host
components that compose the tumor is termed the tumor microenvironment (TME). Host cells …

Understanding the tumor-immune microenvironment in prostate... : Current Opinion in
Oncology Understanding the tumor-immune microenvironment in prostate cancer : Current …

Prostate cancer is the most prevalent type of cancer in senior American men. Currently, the
five-year survival rate after the initial diagnosis of prostate cancer is close to 100 …

Several mechanisms that impair the immune response to promote tumour progression are
reported. These mechanisms aim to reduce the ability of antigen-presenting cells to present …

Prostate cancers (PCa) have been reported to actively suppress antitumor immune
responses by creating an immune-suppressive microenvironment. There is mounting …

Prostate cancer (PC) is one of the most common malignancies among men and is the
second leading cause of cancer death. PC immunotherapy has taken relatively successful …

Immunotherapy is being tested intensively in clinical trials for prostate cancer; it includes
immune checkpoint inhibition, prostate specific antigen (PSA) vaccines and dendritic cell …

Prostate cancer is one of the most common malignant neoplasms in men worldwide, and is
the fifth cause of cancer-related death. In recent years, a new generation of therapies have …